TipRanks
EXACT Therapeutics AS (DE:56F)
FRANKFURT:56F
Germany Market
56F
EXACT Therapeutics AS
RESEARCH TOOLSreports

EXACT Therapeutics AS (56F) Income Statement

0 Followers

EXACT Therapeutics AS Income Statement

Last quarter (Q2 2022), EXACT Therapeutics AS's total revenue was $―, a decrease of ― from previous quarter. In Q2, EXACT Therapeutics AS's net income was $―. See EXACT Therapeutics AS’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 1.82M$ 1.08M$ 402.07K$ 125.50K$ 143.30K
EBITDA
$ -56.66M$ -31.98M$ -14.41M$ -7.45M$ -4.76M
Operating Income
$ -59.11M$ -34.70M$ -15.98M$ -7.62M$ -4.95M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -58.59M$ -33.09M$ -14.82M$ -7.59M$ -4.91M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
 ― ― ― ― ―
Weighted Average Shares Outstanding (Diluted)
 ― ― ― ― ―

EXACT Therapeutics AS Earnings and Revenue History